ARD-2128,99.40%

产品编号:Bellancom-132292| CAS NO:2222111-87-5| 分子式:C45H50ClN7O6| 分子量:820.37

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-132292
7000.00 杭州 北京(现货)
Bellancom-132292
11500.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

ARD-2128

产品介绍 ARD-2128 是一种高效的 PROTAC 雄激素受体 (AR) 降解剂。ARD-2128 可有效降低 AR 蛋白并抑制肿瘤组织中 AR 调节的基因,在没有毒性迹象的情况下抑制肿瘤生长。ARD-2128 作用在前列腺癌的研究上。
生物活性

ARD-2128 is a highly potent, orally bioavailable PROTAC androgen receptor (AR) degrader. ARD-2128 effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity. ARD-2128 has the potential for the research of the prostate cancer.

体外研究

ARD-2128 is highly potent and effective in the inhibition of cell growth in the VCaP cell line and LNCaP cell line with the IC50 values of 4 nM and 5 nM, respectively.
ARD-2128 (1, 10, 100, and 1000 nM; 24 hours) effectively reduces the AR protein level by >50% at 1 nM and achieves the AR degradation of >90% at 10, 100, and 1000 nM, respectively, in VCaP cell.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay

Cell Line: VCaP cell
Concentration: 1, 10, 100, and 1000 nM
Incubation Time: 24 hours
Result: Reduces the AR protein level and achieves the AR degradation.
体内研究
(In Vivo)

ARD-2128 (20 mg/kg; p.o.; once) is effective in reducing the level of AR protein in mice after 24 hours.
ARD-2128 (10-40 mg/kg; p.o.; daily for 21 days) shows antitumor activity in the VCaP xenograft model in mice.
ARD-2128 (5mg/kg; p.o.) treatment shows the Cmax, AUC0-t and t1/2 values of 1304 ng/mL, 22361 ng h/mL and 18.8 hours, respectively.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SCID mice
Dosage: 20 mg/kg
Administration: Oral
Result: Reducing the level of AR protein in mice after 24 hours.
Animal Model: SCID mice
Dosage: 10, 20, and 40 mg/kg
Administration: P.o.; daily for 21 days
Result: Inhibits tumor growth by 46, 69, and 63%, respectively.
Animal Model: Male ICR Mice
Dosage: 5 mg/kg
Administration: P.o. (Pharmacokinetic Analysis)
Result: The Cmax, AUC0-t and t1/2 were 1304 ng/mL, 22361 ng h/mL and 18.8 hours, respectively.
体内研究

ARD-2128 (20 mg/kg; p.o.; once) is effective in reducing the level of AR protein in mice after 24 hours.
ARD-2128 (10-40 mg/kg; p.o.; daily for 21 days) shows antitumor activity in the VCaP xenograft model in mice.
ARD-2128 (5mg/kg; p.o.) treatment shows the Cmax, AUC0-t and t1/2 values of 1304 ng/mL, 22361 ng h/mL and 18.8 hours, respectively.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SCID mice
Dosage: 20 mg/kg
Administration: Oral
Result: Reducing the level of AR protein in mice after 24 hours.
Animal Model: SCID mice
Dosage: 10, 20, and 40 mg/kg
Administration: P.o.; daily for 21 days
Result: Inhibits tumor growth by 46, 69, and 63%, respectively.
Animal Model: Male ICR Mice
Dosage: 5 mg/kg
Administration: P.o. (Pharmacokinetic Analysis)
Result: The Cmax, AUC0-t and t1/2 were 1304 ng/mL, 22361 ng h/mL and 18.8 hours, respectively.
体内研究

ARD-2128 (20 mg/kg; p.o.; once) is effective in reducing the level of AR protein in mice after 24 hours.
ARD-2128 (10-40 mg/kg; p.o.; daily for 21 days) shows antitumor activity in the VCaP xenograft model in mice.
ARD-2128 (5mg/kg; p.o.) treatment shows the Cmax, AUC0-t and t1/2 values of 1304 ng/mL, 22361 ng h/mL and 18.8 hours, respectively.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SCID mice
Dosage: 20 mg/kg
Administration: Oral
Result: Reducing the level of AR protein in mice after 24 hours.
Animal Model: SCID mice
Dosage: 10, 20, and 40 mg/kg
Administration: P.o.; daily for 21 days
Result: Inhibits tumor growth by 46, 69, and 63%, respectively.
Animal Model: Male ICR Mice
Dosage: 5 mg/kg
Administration: P.o. (Pharmacokinetic Analysis)
Result: The Cmax, AUC0-t and t1/2 were 1304 ng/mL, 22361 ng h/mL and 18.8 hours, respectively.
性状Solid
溶解性数据
In Vitro: 

DMSO : 100 mg/mL (121.90 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.2190 mL 6.0948 mL 12.1896 mL
5 mM 0.2438 mL 1.2190 mL 2.4379 mL
10 mM 0.1219 mL 0.6095 mL 1.2190 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服